Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$35.17 - $42.48 $5,416 - $6,541
-154 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$36.14 - $42.24 $8,384 - $9,799
-232 Reduced 60.1%
154 $6,000
Q2 2021

Jul 22, 2021

SELL
$39.85 - $46.63 $1,155 - $1,352
-29 Reduced 6.99%
386 $16,000
Q1 2021

Apr 20, 2021

SELL
$42.34 - $52.82 $1,354 - $1,690
-32 Reduced 7.16%
415 $18,000
Q4 2020

Feb 02, 2021

BUY
$36.12 - $50.05 $2,311 - $3,203
64 Added 16.71%
447 $22,000
Q3 2020

Oct 15, 2020

BUY
$38.56 - $48.36 $7,442 - $9,333
193 Added 101.58%
383 $16,000
Q2 2020

Jul 27, 2020

BUY
$44.5 - $52.11 $8,455 - $9,900
190 New
190 $9,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Evolution Wealth Advisors, LLC Portfolio

Follow Evolution Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.